Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases

Tocilizumab has been recognized as one of the few existing biologic useful for combating COVID-19 infections especially in critically ill patient. We had experience in treating five critically ill patients with severe lung injury who were COVID-19 positive with tocilizumab. In the present case serie...

Descripción completa

Detalles Bibliográficos
Autores principales: ElSeirafi, Mohamed M, Hasan, Hasan MSN, Sridharan, Kannan, Zamoori, Alaa, Alkhawaja, Sana, Pasha, Sheikh Abdul Azeez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308754/
https://www.ncbi.nlm.nih.gov/pubmed/32632355
http://dx.doi.org/10.1016/j.rmcr.2020.101139
_version_ 1783549061159190528
author ElSeirafi, Mohamed M
Hasan, Hasan MSN
Sridharan, Kannan
Zamoori, Alaa
Alkhawaja, Sana
Pasha, Sheikh Abdul Azeez
author_facet ElSeirafi, Mohamed M
Hasan, Hasan MSN
Sridharan, Kannan
Zamoori, Alaa
Alkhawaja, Sana
Pasha, Sheikh Abdul Azeez
author_sort ElSeirafi, Mohamed M
collection PubMed
description Tocilizumab has been recognized as one of the few existing biologic useful for combating COVID-19 infections especially in critically ill patient. We had experience in treating five critically ill patients with severe lung injury who were COVID-19 positive with tocilizumab. In the present case series, we have attempted to summarize their clinical profile, changes in laboratory biomarkers and outcomes.
format Online
Article
Text
id pubmed-7308754
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73087542020-06-23 Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases ElSeirafi, Mohamed M Hasan, Hasan MSN Sridharan, Kannan Zamoori, Alaa Alkhawaja, Sana Pasha, Sheikh Abdul Azeez Respir Med Case Rep Case Report Tocilizumab has been recognized as one of the few existing biologic useful for combating COVID-19 infections especially in critically ill patient. We had experience in treating five critically ill patients with severe lung injury who were COVID-19 positive with tocilizumab. In the present case series, we have attempted to summarize their clinical profile, changes in laboratory biomarkers and outcomes. Elsevier 2020-06-23 /pmc/articles/PMC7308754/ /pubmed/32632355 http://dx.doi.org/10.1016/j.rmcr.2020.101139 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
ElSeirafi, Mohamed M
Hasan, Hasan MSN
Sridharan, Kannan
Zamoori, Alaa
Alkhawaja, Sana
Pasha, Sheikh Abdul Azeez
Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
title Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
title_full Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
title_fullStr Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
title_full_unstemmed Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
title_short Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
title_sort efficacy and safety of tocilizumab in critically ill adults with covid-19 infection in bahrain: a report of 5 cases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308754/
https://www.ncbi.nlm.nih.gov/pubmed/32632355
http://dx.doi.org/10.1016/j.rmcr.2020.101139
work_keys_str_mv AT elseirafimohamedm efficacyandsafetyoftocilizumabincriticallyilladultswithcovid19infectioninbahrainareportof5cases
AT hasanhasanmsn efficacyandsafetyoftocilizumabincriticallyilladultswithcovid19infectioninbahrainareportof5cases
AT sridharankannan efficacyandsafetyoftocilizumabincriticallyilladultswithcovid19infectioninbahrainareportof5cases
AT zamoorialaa efficacyandsafetyoftocilizumabincriticallyilladultswithcovid19infectioninbahrainareportof5cases
AT alkhawajasana efficacyandsafetyoftocilizumabincriticallyilladultswithcovid19infectioninbahrainareportof5cases
AT pashasheikhabdulazeez efficacyandsafetyoftocilizumabincriticallyilladultswithcovid19infectioninbahrainareportof5cases

Ejemplares similares